EUVIMEDOpdag EUVIMED
Crossref

Evaluation of hypolipidemic and hypoglycemic effects of Dillenia indica L. on alloxan-induced diabetic rats

Md Mahfuj Alam Siddiq, Jeasmin Akter, Zakia Sultana Sathi, Md. Ruhul Kuddus, Mohammad A. Rashid

Asian Journal of Pharmacognosy · 2025

DOI: 10.71221/ajp.09308 ↗

At a glance

Journal article in Asian Journal of Pharmacognosy, 2025. Written by Md Mahfuj Alam Siddiq and 4 co-authors.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Context

Dillenia indica L. a tropical fruit-bearing plant native to South and Southeast Asia, has attracted scientific interest due to its rich phytochemical composition and potential therapeutic benefits in managing diabetes, lipid disorders, and oxidative stress.

Objective

The objective of this study was to investigate the potential antidiabetic and lipid-lowering properties of D. indica fruit and bark extracts in a rat model of alloxan-induced type 2 diabetes.

Methods

Diabetes was induced in rats using an intraperitoneal injection of alloxan monohydrate (160 mg/kg) after a 12-hour fast. The chloroform fractions of D. indica fruit and bark (200 mg/kg) were administered intraperitoneally, with metformin (150 mg/kg) serving as the standard drug. Fasting blood glucose (FBG) levels were measured at 0, 24, 40, and 50 hours. Upon completion of the experiment, blood samples were collected for the evaluation of total cholesterol (TC) and triglyceride (TG) levels.

Results

The chloroform fraction of D. indica fruit significantly reduced FBG levels by 65% after 50 hours, closely matching the effect of metformin. It also decreased the elevated TC and TG levels by 60% and 55%, respectively. In contrast, the bark extract initially lowered FBG but caused a 30% rebound increase at 50 hours and led to increased TC and TG levels by 28% and 54%, respectively.

Conclusion

The chloroform fraction of D. indica fruit demonstrates potent antidiabetic and lipid-lowering activity, indicating its promise as a natural therapeutic agent for managing hyperglycemia and dyslipidemia in type 2 diabetes. The inconsistent effects of the bark extract warrant further investigation.

Cite

APA

Siddiq, M. M. A., Akter, J., Sathi, Z. S., Kuddus, M. R., & Rashid, M. A. (2025). Evaluation of hypolipidemic and hypoglycemic effects of Dillenia indica L. on alloxan-induced diabetic rats. Asian Journal of Pharmacognosy. https://doi.org/10.71221/ajp.09308

Vancouver

Siddiq MMA, Akter J, Sathi ZS, Kuddus MR, Rashid MA. Evaluation of hypolipidemic and hypoglycemic effects of Dillenia indica L. on alloxan-induced diabetic rats. Asian Journal of Pharmacognosy. 2025. doi:10.71221/ajp.09308

BibTeX
@article{Siddiq2025,
  author = {Siddiq, Md Mahfuj Alam and Akter, Jeasmin and Sathi, Zakia Sultana and Kuddus, Md. Ruhul and Rashid, Mohammad A.},
  title = {Evaluation of hypolipidemic and hypoglycemic effects of Dillenia indica L. on alloxan-induced diabetic rats},
  journal = {Asian Journal of Pharmacognosy},
  year = {2025},
  doi = {10.71221/ajp.09308}
}
Start for free →